Cytokinetics (CYTK) Change in Cash (2010 - 2026)
Cytokinetics (CYTK) posted quarterly Change in Cash of $7.3 million for Q1 2026, up 134.58% year-over-year from $3.1 million in Q1 2025, and up 107.11% quarter-over-quarter from -$102.9 million in Q4 2025.
Cytokinetics (CYTK) Change in Cash (2010 - 2026) Analysis & Trends
Cytokinetics (CYTK) has reported Change in Cash for 17 consecutive years, with $7.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 134.58% year-over-year to $7.3 million; the TTM figure through Mar 2026 stood at $58.9 million (up 227.22% YoY), while the FY2025 annual figure was $30.4 million, up 267.34% from the prior year.
- Change in Cash grew to $7.3 million in Q1 2026 per CYTK's latest filing, from -$102.9 million in the prior quarter.
- Across five years, Change in Cash topped out at $152.0 million in Q3 2025 and bottomed at -$143.3 million in Q3 2024.
- Historically, Change in Cash has averaged $1.2 million across 5 years, with a median of $7.0 million in 2024.
- Annual changes were most pronounced in 2023 — Change in Cash surged 1207.47% — and 2024, when it tumbled 561.32%.
- Cytokinetics' Change in Cash stood at -$39.1 million in 2022, then soared by 134.14% to $13.3 million in 2023, then jumped by 259.8% to $48.0 million in 2024, then slumped by 314.61% to -$102.9 million in 2025, then soared by 107.11% to $7.3 million in 2026.
- Business Quant data shows CYTK's Change in Cash at $7.3 million in Q1 2026, -$102.9 million in Q4 2025, and $152.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn | 125.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 125.42 Mn |
| Mar 31, 2026 | 7.32 Mn |
| Dec 31, 2025 | -102.95 Mn |
| Sep 30, 2025 | 152.03 Mn |
| Jun 30, 2025 | 2.50 Mn |
| Mar 31, 2025 | -21.18 Mn |
| Dec 31, 2024 | 47.97 Mn |
| Sep 30, 2024 | -143.25 Mn |
| Jun 30, 2024 | 70.17 Mn |
| Mar 31, 2024 | 6.95 Mn |
| Dec 31, 2023 | 13.33 Mn |
| Sep 30, 2023 | 31.05 Mn |
| Jun 30, 2023 | -34.20 Mn |
| Mar 31, 2023 | 36.03 Mn |
| Dec 31, 2022 | -39.06 Mn |
| Sep 30, 2022 | 12.61 Mn |
| Jun 30, 2022 | -21.79 Mn |
| Mar 31, 2022 | 2.76 Mn |
| Dec 31, 2021 | 22.10 Mn |
| Sep 30, 2021 | 53.41 Mn |